Discrepancy between perceptions and acceptance of clinical decision support Systems: implementation of artificial intelligence for vancomycin dosing
Open Access
- 11 August 2023
- journal article
- research article
- Published by Springer Nature in BMC Medical Informatics and Decision Making
- Vol. 23 (1) , 1-9
Abstract
Background: Artificial intelligence (AI) tools are more effective if accepted by clinicians. We developed an AI-based clinical decision support system (CDSS) to facilitate vancomycin dosing. This qualitative study assesses clinicians' perceptions regarding CDSS implementation. Methods: Thirteen semi-structured interviews were conducted with critical care pharmacists, at Mayo Clinic (Rochester, MN), from March through April 2020. Eight clinical cases were discussed with each pharmacist (N = 104). Following initial responses, we revealed the CDSS recommendations to assess participants' reactions and feedback. Interviews were audio-recorded, transcribed, and summarized. Results: The participants reported considerable time and effort invested daily in individualizing vancomycin therapy for hospitalized patients. Most pharmacists agreed that such a CDSS could favorably affect (N = 8, 62%) or enhance (9, 69%) their ability to make vancomycin dosing decisions. In case-based evaluations, pharmacists' empiric doses differed from the CDSS recommendation in most cases (88/104, 85%). Following revealing the CDSS recommendations, we noted 78% (69/88) discrepant doses. In discrepant cases, pharmacists indicated they would not alter their recommendations. The reasons for declining the CDSS recommendation were general distrust of CDSS, lack of dynamic evaluation and in-depth analysis, inability to integrate all clinical data, and lack of a risk index. Conclusion: While pharmacists acknowledged enthusiasm about the advantages of AI-based models to improve drug dosing, they were reluctant to integrate the tool into clinical practice. Additional research is necessary to determine the optimal approach to implementing CDSS at the point of care acceptable to clinicians and effective at improving patient outcomes.Keywords
Funding Information
- Center for Individualized Medicine, Mayo Clinic (J011972)
This publication has 35 references indexed in Scilit:
- Vancomycin-Associated Nephrotoxicity in the Critically IllCritical Care Medicine, 2014
- Standards for Reporting Qualitative ResearchAcademic Medicine, 2014
- Systematic Review and Meta-Analysis of Vancomycin-Induced Nephrotoxicity Associated with Dosing Schedules That Maintain Troughs between 15 and 20 Milligrams per LiterAntimicrobial Agents and Chemotherapy, 2013
- A higher dose of vancomycin in continuous infusion is needed in critically ill patientsInternational Journal of Antimicrobial Agents, 2011
- Use of vancomycin pharmacokinetic–pharmacodynamic properties in the treatment of MRSA infectionsExpert Review of Anti-infective Therapy, 2010
- Vancomycin Therapeutic Guidelines: A Summary of Consensus Recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases PharmacistsClinical Infectious Diseases, 2009
- The coming of age of artificial intelligence in medicineArtificial Intelligence in Medicine, 2009
- Better outcomes through continuous infusion of time-dependent antibiotics to critically ill patients?Current Opinion in Critical Care, 2008
- Using thematic analysis in psychologyQualitative Research in Psychology, 2006
- Vancomycin: A 50-Year ReassessmentClinical Infectious Diseases, 2006